Genetic variation
16:g.89960104T>C
This variation affects:
Overview
16:g.89960104T>C is a genetic variant associated with Actinic keratosis and Vitiligo.
This variant is located on chromosome 16. The variations at position 89960104 are the genetic letters C/C, T/T, C/T
Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant 16:g.89960104T>C there are 3 currently known genotypes : C/C, T/T or C/T
Short Overview
Variant Location
16:g.89960104T>C is located on gene in chromsome 16. Use the genome browser to explore the location of 16:g.89960104T>C and its genetic neighbourhood.
Conditions & Traits
16:g.89960104T>C affects the following conditions and traits:
Pharmacogenetics
16:g.89960104T>C affects the following drugs:
Diagnostics
16:g.89960104T>C is commonly tested together with other variants on the same gene.
Genome Browser
This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant . Explore more variants and their effects on the body by browsing left and right along the DNA strand.
Did you know genetic variants affect drugs?
Mutations are random changes in the DNA and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.
Dr. Wallerstorfer
Conditions & Traits of 16:g.89960104T>C
The different genotypes of variant 16:g.89960104T>C can affect the expression or likelyhood of developing certain traits or conditions. Current research shows that 2 conditions and 0 traits are associated with 16:g.89960104T>C. The following table shows the relationship between genotypes and conditions and traits.
Did you know genetic variants affect drugs?
Genetic variants can influence how our body reacts to certain drugs. The presence of specific genetic variants can increase or decrease the efficiency and effectiveness of a drug, impacting how well it works inside our system. Additionally, certain genetic variants can heighten or lessen the toxicity of a drug, thereby affecting the risk of unwanted side effects. They can also alter how a drug is metabolized, which influences the appropriate dosage one should receive.
Dr. Wallerstorfer
Variant Classification based on Scientific Studies
Scientific studies classifications aim to uncover how genetic variants function and their roles in diseases, traits, and evolution. Variants are categorized based on their functional impact, such as loss-of-function (reduces gene activity), gain-of-function (increases gene activity), neutral (no significant impact), or evolutionary conservation. This classification uses experimental data, population studies, and computational analyses to understand variant effects. Unlike clinical testing, which focuses on immediate health impacts, scientific studies explore broader genetic mechanisms and long-term implications.
Genotype
C
C
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Genotype
C
T
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Genotype
C
C
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Genotype
C
T
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Genotype
T
T
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Genotype
C
T
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Genotype
T
T
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Genotype
C
T
Level of evidence
No Effect
Unisex
0 Sources
Participants: 0
No available data
Pharmacogenetics
The genetic variant 16:g.89960104T>C impacts how certain medications work in the body. This difference may cause some of us to require different dosage amounts to achieve the desired effects, while others might experience more apparent side-effects. As a result, healthcare providers may need to adjust prescriptions for those individuals with 16:g.89960104T>C. Ultimately, understanding our genetic makeup helps improve the overall effectiveness and usability of medications. Tailoring treatments based on genetics ensures a safer, more personalized healthcare experience.
Drugs related to 16:g.89960104T>C
All drugs that are linked to 16:g.89960104T>C are listed here.
Diagnostics
16:g.89960104T>C is commonly tested together with other variants on the same gene.
Related variants
Conditions and traits are often affected by more than one variant. It is important to understand these other factors to get a better understanding of how genetics affect certain conditions and traits. The following grid shows other variants that affect the same conditions and traits as 16:g.89960104T>C.
Genotype Distribution
Knowing your genome can actually tell you a lot about your ancestors.
The prevalence of the different genotypes is based on the native inhabitants of a region. In the map below you see how common each genotype is in the native inhabitants of those regions. Since genetic material is passed down form generation to generation, your DNA shows traces of the geographical origins of your ancestors.
This data is based on “The 1000 Genomes Project” which established one of the most detailed overviews of human genetic variations across the globe. The regions are broadly categorized into five continental groups: Africa, America, Europe, South Asia and East Asia. All continental groups together display the global prevalence. Click through the regions, to learn more about the local prevalence of the possible genotypes.
At present, there is no distribution data available for SNP 4268748. 4268748.
Studies and Sources
All of the resources below examine variant
Fan Liu, Mijke Visser, David L Duffy, Pirro G Hysi, Leonie C Jacobs, Oscar Lao, Kaiyin Zhong, Susan Walsh, Lakshmi Chaitanya, Andreas Wollstein, Gu Zhu, Grant W Montgomery, Anjali K Henders, Massimo Mangino, Daniel Glass, Veronique Bataille, Richard A Sturm, Fernando Rivadeneira, Albert Hofman, Wilfred F J van IJcken, André G Uitterlinden, Robert-Jan T S Palstra, Timothy D Spector, Nicholas G Martin, Tamar E C Nijsten, Manfred Kayser
Maryam M Asgari, Wei Wang, Nilah M Ioannidis, Jacqueline Itnyre, Thomas Hoffmann, Eric Jorgenson, Alice S Whittemore
Ying Jin, Genevieve Andersen, Daniel Yorgov, Tracey M Ferrara, Songtao Ben, Kelly M Brownson, Paulene J Holland, Stanca A Birlea, Janet Siebert, Anke Hartmann, Anne Lienert, Nanja van Geel, Jo Lambert, Rosalie M Luiten, Albert Wolkerstorfer, J P Wietze van der Veen, Dorothy C Bennett, Alain Taïeb, Khaled Ezzedine, E Helen Kemp, David J Gawkrodger, Anthony P Weetman, Sulev Kõks, Ele Prans, Külli Kingo, Maire Karelson, Margaret R Wallace, Wayne T McCormack, Andreas Overbeck, Silvia Moretti, Roberta Colucci, Mauro Picardo, Nanette B Silverberg, Mats Olsson, Yan Valle, Igor Korobko, Markus Böhm, Henry W Lim, Iltefat Hamzavi, Li Zhou, Qing-Sheng Mi, Pamela R Fain, Stephanie A Santorico, Richard A Spritz